Primary Record
Faropenem daloxate
Note: Only for scientific research or as raw materials for production.
- In stock
- 8,789 g
- Purity
- 98.5 %
- CAS
- 141702-36-5
Compound Identifiers & Properties
- CAS
- 141702-36-5
- PubChem CID
- 6918218
- SMILES
- CC1=C(OC(=O)O1)COC(=O)C2=C(S[C@H]3N2C(=O)[C@@H]3[C@@H](C)O)[C@H]4CCCO4
- Canonical SMILES
- Cc1oc(=O)oc1COC(=O)C1=C([C@H]2CCCO2)S[C@@H]2[C@@H]([C@@H](C)O)C(=O)N12
Names & Synonyms
- Faropenem daloxate
- Faropenem medoxomil
- Faropenem medoxil
- Fropenem daloxate
- Orapem
- faropenem
- 141702-36-5
- faropenem-medoxomil
- Faropenem medoxomil [USAN]
- SUN-A0026
- RefChem:139970
- 5OK523O4FU
- GlyTouCan:G42504UN
- UNII-5OK523O4FU
- AC1OCF65
- SUN-208
- C17H19NO8S
- Faropenem medoxomil (USAN)
- SUN208
- BAY-56-6854
- a-0026
- orb1309681
- SCHEMBL2334640
- FAROPENEM DALOXATE [MI]
- CHEMBL1257070
- SUN A0026
- SUN 208
- BAY566854
- CHEBI:134710
- A0026
- BAY 566854
- BAY-566854
- BAY56-6854
- G42504UN
- ZINC3806644
- BAY 56-6854
- C17-H19-N-O8-S
- 3667AH
- EX-A12269
- AKOS030526093
- CID6918218
- CS-0390
- DB05659
- AN-31646
- BC252325
- DA-73311
- HY-10004
- MS-26703
- A 0026
- NS00069240
- J1.802.218D
- D08919
- F83978
- W-5213
- 4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, (5R,6S)-
- 702F365
- A911194
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
- BRD-K59045783-001-01-1
- BRD-K59045783-001-02-9
- Q27095691
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-((1R)-1-hydroxyethyl)-7-oxo-3-((2R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-tetrahydrofuran-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
- (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((R)-2-tetrahydrofuryl)-4-thia-1-aza-bicyclo(3,2,0)hept-2-ene-carboxylate
- (5-METHYL-2-OXO-1,3-DIOXOREN-4-YL)METHYL(5R,6S)-6-((R)-1-HYDROXYETHYL)-7-OXO-3-((R)-2-TETRAHYDROFURYL)-4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLATE
- (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl (5R,6S)-6-((1R)-1-hydroxyethyl)-7-oxo-3-((2R)-oxolan-2-yl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate
- (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
- (5R,6S)-6-[(1R)-1-Hydroxyethyl]-7-oxo-3-[(2R)-oxolane-2-yl]-4-thia-1-azabicyclo[3.2.0]hepta-2-ene-2-carboxylic acid 5-methyl-2-oxo-1,3-dioxole-4-ylmethyl ester
- (5R,6S)-6-[1(R)-Hydroxyethyl]-2-[2(R)-tetrahydrofuryl]-2-penem-3-carboxylic acid 5-methyl-2-oxo-1,3-dioxol-4-ylmethyl ester
- 4-Thia-1-azabicyclo(.32.0)hept-2-ene-2-carboxylic acid, 6-((1R)-1-hydroxyethyl)-7-oxo-3-((2R)-tetrahydro-2-furanyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, (5R,6S)-
- 4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 6-((1R)-1-HYDROXYETHYL)-7-OXO-3-((2R)-TETRAHYDRO-2-FURANYL)-, (5-METHYL-2-OXO-1,3-DIOXOL-4-YL)METHYL ESTER, (5R,6S)
- 4-Thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-7-oxo-3-(tetrahydro-2-furanyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, (5R-(3(R*),5alpha,6alpha(R*)))-